Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01222871 · ClinicalTrials.gov registry record · Phase 1
Treatment of Early Nasal Polyposis With Topical Triamcinolone
A Phase 1 study, sponsored by Steward St. Elizabeth's Medical Center of Boston.
- Terminated
- Registry status
- Phase 1
- Development phase
- 1
- Enrollment target
NCT01222871 is a Phase 1 study that was terminated before completion, run by Steward St. Elizabeth's Medical Center of Boston. The registered enrollment target is 1 participants.
The verdict
NCT01222871, a Phase 1 study, was terminated before completion, sponsored by Steward St. Elizabeth's Medical Center of Boston.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 1 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the effectiveness of intranasal Triamcinolone delivered through a bio-absorbable nasal dressing verses oral steroids and a saline soaked dressing, in the treatment and prevention of early nasal polyposis.
Interventions
- DRUG Triamcinolone
- DRUG Saline soaked sponge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2010-07 |
| Est. Completion | 2012-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01222871
The ClinicalTrials.gov registry entry for NCT01222871 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Steward St. Elizabeth's Medical Center of Boston, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Triamcinolone is the first listed.
NCT01222871 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01222871 about?
NCT01222871 is a clinical study titled "Treatment of Early Nasal Polyposis With Topical Triamcinolone". The purpose of this study is to compare the effectiveness of intranasal Triamcinolone delivered through a bio-absorbable nasal dressing verses oral steroids and a saline soaked dressing, in the treatment and prevention of early nasal polyposis.
What is the current status of trial NCT01222871?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 1 participants. The study started on 2010-07. Estimated completion is 2012-08.
What interventions are being tested in trial NCT01222871?
The interventions under investigation include: Triamcinolone (DRUG), Saline soaked sponge (DRUG).
Who is sponsoring clinical trial NCT01222871?
This trial is sponsored by Steward St. Elizabeth's Medical Center of Boston, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.